Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes (JANUB48)

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Patrick Couture, Laval University Identifier:
First received: April 11, 2011
Last updated: February 6, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)